Johanniskraut Bombastus-Werke (Hypericum Perforatum)

Johanniskraut Bombastus-Werke is used in the context of mild mood and skin health support.

• Mild to moderate depression: may help improve mood and emotional balance in adults.
• Seasonal affective disorder: may reduce depressive symptoms associated with winter months.
• Minor skin irritations: may provide soothing relief for superficial skin inflammation.

• Hypericum perforatum contains bioactive constituents such as hypericin and hyperforin that modulate neurotransmitter activity, inhibit monoamine oxidase, and influence inflammatory pathways. These actions are thought to contribute to mood‑regulating effects and local anti‑inflammatory activity when applied to the skin.

Adverse reactions reported with Hypericum perforatum preparations vary in frequency and severity.

Common Side Effects

• Gastrointestinal upset: nausea, stomach discomfort.
• Dry mouth: reduced salivation.
• Dizziness or light‑headedness.
• Fatigue or mild tiredness.
• Photosensitivity: increased skin sensitivity to sunlight.
• Headache: mild to moderate.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, difficulty breathing.
• Serotonin syndrome: risk when combined with serotonergic drugs.
• Significant liver enzyme elevation.
• Extreme photosensitivity leading to burns.
• Hemorrhagic events when used with anticoagulants.

When considering Johanniskraut Bombastus-Werke, several safety points should be observed.

• Pregnancy: safety not established; avoid unless advised by a healthcare professional.
• Breastfeeding: insufficient data; use with caution.
• Drug interactions: review concomitant serotonergic or anticoagulant therapy.
• Photosensitivity: limit exposure to direct sunlight and use protective clothing.
• Hepatic impairment: monitor liver function if underlying liver disease exists.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Hypericum perforatum can affect the metabolism of several medicines.

Major Interactions (Avoid)

• Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome.
• Monoamine oxidase inhibitors (MAOIs): potential severe hypertensive reactions.
• Tricyclic antidepressants: may reduce therapeutic effect.
• Warfarin and other anticoagulants: increased bleeding risk.
• Oral contraceptives: reduced contraceptive efficacy.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): possible increased bleeding.
• Antihistamines: may enhance sedative effects.
• Antiretroviral agents: altered plasma concentrations.
• Cyclosporine: potential reduction in immunosuppressive activity.
• Digoxin: possible change in drug levels.